The global eClinical solutions market size is expected to reach USD 21.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.6% from 2022 to 2030. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.
As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development processes are poised to boost market growth over the forecast period. Moreover, digital transformation in the field of clinical trials and preference for data-centric approaches are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to the massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and by reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.
Increasing adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision-making in each stage of development. It also helps reduce cost and time between the development phase by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which helps make quick decisions. Market players engage in new product development and strategic alliances including partnership agreements, promotional activities, and acquisitions to keep market rivalry high. For instance, in October 2020, Oracle entered into collaboration with FHI Clinical Inc. for improving clinical trial efficiency and to get therapies to market faster.
Request a free sample copy or view report summary: eClinical Solutions Market Report
CTMS led the product segment in 2021 and accounted for a revenue share of around 21% owing to benefits of the product such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
The cloud-based systems segment is anticipated to exhibit an exponential CAGR of 15.1% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring
The CROs segment held the largest revenue share in the market in 2021. The segment is projected to rise at a remarkable CAGR of 13.9% during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure
Key companies engage in various business strategies such as mergers and acquisitions and new product development to gain greater market share
Grand View Research has segmented the global eClinical solutions market on the basis of product, delivery mode, development phase, end-use, and region:
eClinical Solutions Product Outlook (Revenue, USD Million, 2017 - 2030)
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
Clinical Trial Management Systems (CTMS)
Clinical Analytics Platforms
Randomization and Trial Supply Management (RTSM)
Clinical Data Integration Platforms
Electronic Clinical Outcome Assessment (eCOA)
Safety Solutions
Electronic Trial Master File (eTMF)
eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)
Web-hosted (On-Demand)
Licensed Enterprise (On-premise)
Cloud-based
eClinical Solutions Development Phase Outlook (Revenue, USD Million, 2017 - 2030)
Phase I
Phase II
Phase III
Phase IV
eClinical Solutions End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospitals/Healthcare providers
CROs
Academic Institutes
Pharma & Biotech Organizations
Medical Device Manufacturers
eClinical Solutions Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Netherlands
Sweden
Denmark
Asia Pacific
Japan
China
India
South Korea
Australia
New Zealand
Taiwan
Hong Kong
Singapore
Thailand
Vietnam
Central & South America
Brazil
Argentina
Chile
MEA
South Africa
Saudi Arabia
United Arab Emirates (UAE)
Egypt
Qatar
List of Key Players of eClinical Solutions Market
DATATRAK International, Inc
Oracle
Parexel International Corporation
Dassault Systemes
Bioclinica
CRF Health
ERT Clinical
eClinicalWorks
IBM Watson Health
Anju Life Sciences Software
eClinical Solutions
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."